NiCord (cord blood-derived exvivo expanded CD34+ cells and the non-expanded cell fraction of the same cord blood unit) | |
---|---|
Trade Name | |
Orphan Indication | Chronic myeloid leukemia |
USA Market Approval | USA |
USA Designation Date | 2016-11-09 00:00:00 |
Sponsor | Gamida Cell Ltd.;P. O. Box 34670;Jerusalem |
Related Access Program
Pusan National University Hospital – Chronic Myeloid Leukemia
University of California, San Francisco – Chronic Myeloid Leukemia
Emory University – Chronic Myeloid Leukemia
Pusan National University Hospital – Chronic myeloid leukemia
University of California, San Francisco – Chronic myeloid leukemia
Pfizer – Chronic myeloid leukemia
Emory University – Chronic myeloid leukemia